Notícias

It's extremely difficult to think and act in a contrarian manner, but sometimes this path has greater upside.

Anthropic's revenue is exploding -- and Amazon and SpaceX are cashing in on the AI boom before any IPO even happens.

Alphabet has had a strong year, and a 2X leveraged ETF tracking it sounds like an even better deal until you see the actual returns and realize something quietly eroded a significant chunk of the expected gains.

The data analytics giant's stock has rallied in recent weeks.

Stocks with lofty valuations can be extra vulnerable when the broader market suffers a correction.

Meta Platforms' revenue growth is accelerating thanks in part to its AI efforts, but the scale of its infrastructure spending is increasing its long-term financial risk.

The size of New York's tech talent workforce surpassed the San Francisco Bay Area for the first time as tech companies lay off workers, a new report from CBRE shows.

The Vanguard Growth ETF has doubled during the past three years. But the rally may not be over.

The market spent Tuesday worrying that AI demand will fade. Both companies had just reported the opposite.

XRP's upside potential may not be as high as some investors think.

Exchange-traded funds could be ramping up their SpaceX holdings as shares are unlocked and the stock price recovers.

Improving growth prospects, better value, and lesser tech exposure could make international stocks an intriguing pick for the next decade.

Wall Street's record-breaking initial public offering (IPO) now makes up a significant portion of Nvidia's invested assets.

Gold is mounting a recovery after suffering a sharp decline from its January peak.

In August 2026, Lockheed Martin and partners including Verizon, NVIDIA, Keysight Technologies, ODC and Astris AI showcased the NetSense Airspace Awareness-as-a-Service system, advanced NGI Stage 2 testing, expanded its Strigo modular defense solutions, and supported Firefly Aerospace’s extended launch agreement to enhance responsive space access. Together with over US$152 million in recent Department of Defense contracts and inclusion in a US$920 million Air Force award pool, these moves...

Investors who want to beat the S&P 500 may want to give these growth stocks a closer look.

Amazon invested just $13 billion in Anthropic.

Retail sentiment on Stocktwits remained ‘neutral’ on SPY and QQQ.

TSMC and ASML are two of the more important companies in the chip realm.

Don't be fooled by Buffett's latest buying spree.

Druckenmiller has admitted to recognizing that he sold Nvidia stock too soon back in 2024.

Space Exploration Technologies' staggered and accelerated share unlock schedule is a disaster in the making for retail investors.

Control of Congress may not matter as much as you'd think.

The transaction was reportedly worth a little more than $8bn.

These companies are poised to thrive as data centers require more electricity than ever before.

Nebius just announced its third major debt issue in a year to support its massive AI infrastructure expansion.

You could do a thought experiment to gauge your appetite for outsize holdings, says Cindy Wilson, a certified financial planner at HB Wealth in Alpharetta, Ga. For example, if a client was sitting on a $500,000 position in Apple Wilson would ask, what if they had $500,000 in cash instead? Before deciding whether to sell, consider how much capital-gains tax you may owe if you sell shares in a taxable account.

In August 2026, Regeneron Pharmaceuticals announced that the US FDA approved Pasatru (garetosmab-grts) to reduce new heterotopic ossification lesions and flare-ups in adults with fibrodysplasia ossificans progressiva, based on positive Phase 3 OPTIMA trial results. This approval adds a rare-disease monoclonal antibody to Regeneron’s portfolio, reinforcing the company’s focus on specialized, high-complexity immunology therapies. We’ll now examine how Pasatru’s FOP approval, as an ultra-rare...

The share count hasn't budged since March. The value more than tripled. The difference matters for anyone who owns the chipmaker's stock.

Investors are excited about a lucrative chip supply deal with an AI titan.